Format

Send to

Choose Destination
Eur J Hum Genet. 2013 Nov;21(11):1260-5. doi: 10.1038/ejhg.2013.37. Epub 2013 Mar 6.

Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration.

Author information

1
Department of NVS, Karolinska Institutet, KI-Alzheimer Disease Research Center, Stockholm, Sweden.

Abstract

Frontotemporal lobar degeneration (FTLD) is a progressive neurodegenerative disease with an age at onset generally below 65 years. Mutations in progranulin (GRN) have been reported to be able to cause FTLD through haploinsufficiency. We have sequenced GRN in 121 patients with FTLD and detected six different mutations in eight patients: p.Gly35Glufs*19, p.Asn118Phefs*4, p.Val200Glyfs*18, p.Tyr294*, p.Cys404* and p.Cys416Leufs*30. Serum was available for five of the mutations, where the serum-GRN levels were found to be >50% reduced compared with FTLD patients without GRN mutations. Moreover, the p.Cys416Leufs*30 mutation segregated in an affected family with different dementia diagnoses. The mutation frequency of GRN mutation was 6.6% in our FTLD cohort.

PMID:
23463024
PMCID:
PMC3798842
DOI:
10.1038/ejhg.2013.37
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central Icon for Karolinska Institutet, Link to Full Text
Loading ...
Support Center